Prahlad Singh

Prahlad Singh has a diverse and extensive work experience spanning over several companies. Currently, they hold the position of President and Chief Executive Officer at Revvity since 2023. Prior to that, Prahlad served as the President and Chief Executive Officer at PerkinElmer, Inc. from 2020 to 2023. Before that, they held various roles at PerkinElmer, including President and COO, Executive Vice President and President of Diagnostics, and SVP and Group President of Diagnostics. Prahlad also worked at GE Healthcare as the General Manager of the Women's Health Care Business and as the Managing Director of Strategy, Business Development, and M&A. Prahlad also held roles at Philips Healthcare as the Senior Director of Strategy, Business Development, and M&A. Prahlad began their career at Bristol-Myers Squibb Medical Imaging as the Director of Strategy and Business Development and at DuPont Pharmaceuticals as the Director of Emerging Markets.

Prahlad Singh pursued a PhD in Chemistry from the University of Missouri-Columbia from 1988 to 1992. Prahlad then obtained an MBA from the D'Amore-McKim School of Business at Northeastern University from 1998 to 2000.